Evidence map›Paper›PMID 35540451›Full record

ArticleRSC advances2018

Preparation,

Yu Fang, Dawei Wang, Xingyu Xu, Gila Dava, Jianping Liu, Xiang Li, Qianqian Xue, Huan Wang, Jiangshan Zhang, Huabei Zhang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Unraveling the therapeutic potential ofIn silico pharmacology · 2024
    Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yu FangKey Laboratory of Radiopharmaceuticals of Ministry of Education, College of Chemistry, Beijing Normal University No. 19 Xinjiekouwai Street, Haidian District Beijing 100875 People's Republic of China hbzhang@bnu.edu.cn +86-10-58822012.ORCID https://orcid.org/0000-0002-4728-2418
Dawei WangKey Laboratory of Radiopharmaceuticals of Ministry of Education, College of Chemistry, Beijing Normal University No. 19 Xinjiekouwai Street, Haidian District Beijing 100875 People's Republic of China hbzhang@bnu.edu.cn +86-10-58822012.
Xingyu XuKey Laboratory of Radiopharmaceuticals of Ministry of Education, College of Chemistry, Beijing Normal University No. 19 Xinjiekouwai Street, Haidian District Beijing 100875 People's Republic of China hbzhang@bnu.edu.cn +86-10-58822012.
Gila DavaKey Laboratory of Radiopharmaceuticals of Ministry of Education, College of Chemistry, Beijing Normal University No. 19 Xinjiekouwai Street, Haidian District Beijing 100875 People's Republic of China hbzhang@bnu.edu.cn +86-10-58822012.
Jianping LiuKey Laboratory of Radiopharmaceuticals of Ministry of Education, College of Chemistry, Beijing Normal University No. 19 Xinjiekouwai Street, Haidian District Beijing 100875 People's Republic of China hbzhang@bnu.edu.cn +86-10-58822012.
Xiang LiKey Laboratory of Radiopharmaceuticals of Ministry of Education, College of Chemistry, Beijing Normal University No. 19 Xinjiekouwai Street, Haidian District Beijing 100875 People's Republic of China hbzhang@bnu.edu.cn +86-10-58822012.
Qianqian XueKey Laboratory of Radiopharmaceuticals of Ministry of Education, College of Chemistry, Beijing Normal University No. 19 Xinjiekouwai Street, Haidian District Beijing 100875 People's Republic of China hbzhang@bnu.edu.cn +86-10-58822012.
Huan WangKey Laboratory of Radiopharmaceuticals of Ministry of Education, College of Chemistry, Beijing Normal University No. 19 Xinjiekouwai Street, Haidian District Beijing 100875 People's Republic of China hbzhang@bnu.edu.cn +86-10-58822012.
Jiangshan ZhangCollege of Chemistry and Chemical Engineering, Anyang Normal University No. 436 Xian'ge Avenue Anyang 455000 People's Republic of China.
Huabei ZhangKey Laboratory of Radiopharmaceuticals of Ministry of Education, College of Chemistry, Beijing Normal University No. 19 Xinjiekouwai Street, Haidian District Beijing 100875 People's Republic of China hbzhang@bnu.edu.cn +86-10-58822012.
Beijing Normal University · CNAnyang Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Focal adhesion kinase (FAK) has been identified as a promising target in the early diagnosis and therapy of tumor. In this work, we obtained and evaluated another two novel pyrimidine-based F-18 labeled tumor imaging agents targeting FAK. Among them, the corresponding F-19 standards [

Identifiers

PMID35540451
PMCPMC9078890
OpenAlexW2793720789

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.